MRI Dixon Fat-Corrected Look-Locker T1 Mapping for Quantification of Liver Fibrosis and Inflammation-A Comparison

Jeremias Bendicht Klaus1, Ute Goerke, Markus Klarhöfer

  • 1From the Department of Diagnostic, Interventional, and Pediatric Radiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland (J.B.K., B.J., L.E., A.C., V.C.O., A.T.H.); Institute of Forensic Medicine, University of Bern, Bern, Switzerland (J.B.K.); Dr. Kurz Röntgeninstitut AG, Thun, Switzerland (J.B.K.); Siemens Medical Solutions USA, Tucson, AZ (U.G., M.K.); Siemens Medical Solutions USA, New York, NY (M.B.K.); Department of Hepatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland (A.B.); Department of Radiology and Nuclear Medicine, Lucerne Cantonal Hospital, University of Lucerne, Lucerne, Switzerland (L.E., J.R., A.T.H.); and Liver Elastography Center, Translational Imaging Center, Swiss Institute for Translational and Entrepreneurial Medicine, Bern, Switzerland (A.C., V.C.O., A.T.H.).

Investigative Radiology
|November 8, 2024
PubMed
Summary

A new Dixon water-only T1 mapping technique shows less dependency on liver steatosis for identifying liver fibrosis and inflammation compared to the standard shMOLLI sequence, potentially improving diagnostic accuracy.